As already postulated by published guidelines about the follow-up of childhood cancer survivors (23), these findings emphasize the need for life-long follow-up of gonadal health in patients who underwent HSCT, as a remarkable reduction of testosterone may occur when increased LH values no longer compensate a progressively declining testicular function. Here, PLOD1 is linked to cancer.